We Venture Capital is the corporate venture capital arm of Werfen, a Barcelona-based global leader in specialised diagnostics. The unit invests in disruptive technologies expected to shape the future of the diagnostics industry, deploying capital to back innovation at the intersection of emerging diagnostic technology and clinical application.
As a strategic investor, We Venture Capital operates within Werfen's broader corporate framework, focusing its deal flow on technologies aligned with its parent company's core competency in diagnostics. This positions the firm as both a financial and strategic partner for portfolio companies seeking access to domain expertise and commercial pathways within the global diagnostics ecosystem.
The venture arm's investment activity is concentrated in the diagnostics vertical, with particular attention to emerging diagnostic technologies that could complement or extend Werfen's existing product lines and market position.
